All (2)News (2)Transcripts (0)Press Releases (0)

News18 days ago

Rani Therapeutics Faces Stock Decline Post Financial Results

Rani Therapeutics shares are trading lower after the company reported third-quarter 2025 financial results amidst high expectations but offered no new significant analyst ratings.

News134 days ago

Rani Therapeutics Presents Promising Data at ENDO 2025

Rani Therapeutics shares are trading higher after the company presented data at ENDO 2025 demonstrating bioequivalence of its RaniPill for oral delivery of a bispecific GLP-1/GLP-2 receptor agonist compared to subcutaneous injection.